Human clinical trials are limited, and BPC-157 has not completed the rigorous FDA approval process required to be marketed as a drug for human use
This effect contributes to its potential neuroprotective and cardioprotective benefits
Anastasia Shapoval Metabolic Programs and Weight Control Specialist Article author DOZA Team Weight Management and Healthy Lifestyle Experts The DOZA team of specialists with years of experience in personalized weight loss programs with Mounjaro
BPC-157 promotes organized blood vessel formation through the Egr-1/NAB2 pathway, which acts as both an accelerator and a brake to prevent aberrant vessel growth
However, human clinical trials are limited and hence, this peptide should not be regarded as a treatment for cancer
No human studies have assessed chronic administration effects on brain structure, function, or neurotransmitter systems